MEDICINOVA INC
For the period ended Dec 31, 2023. Filed Feb 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 15, 2024
MNOV$1.47+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $50,999,442 | $18,505,493 |
| Prepaid expenses and other current assets | 174,938 | 499,403 |
| Investments | — | 39,982,213 |
| Total current assets | 51,174,380 | 58,987,109 |
| Goodwill | 9,600,240 | 9,600,240 |
| In-process research and development | 4,800,000 | 4,800,000 |
| Property and equipment, net | 45,800 | 45,269 |
| Right-of-use asset | 575,406 | 629,495 |
| Other non-current assets | 74,151 | 92,792 |
| Total assets | $66,269,977 | $74,154,905 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,003,937 | $424,646 |
| Accrued liabilities and other current liabilities | 2,059,238 | 2,605,308 |
| Operating lease liability | 215,926 | 157,505 |
| Total current liabilities | 3,279,101 | 3,187,459 |
| Deferred tax liability | 201,792 | 201,792 |
| Other non-current liabilities | 410,660 | 523,619 |
| Total liabilities | 3,891,553 | 3,912,870 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2023 and December 31, 2022; 49,046,246 and 49,046,246 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 49,046 | 49,046 |
| Additional paid-in capital | 478,149,161 | 477,438,451 |
| Accumulated other comprehensive loss | (118,090) | (115,285) |
| Accumulated deficit | (415,701,693) | (407,130,177) |
| Total stockholders’ equity | 62,378,424 | 70,242,035 |
| Total liabilities and stockholders’ equity | $66,269,977 | $74,154,905 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.